China's retaliatory tariffs on US could mean more headwinds for drugmakers
China’s announcement of 34% tariffs on all US imports — a retaliation against US tariffs that were announced this week — could create more …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
